Generation gap: Three generations of process research and development towards the industrial manufacture of sitagliptin phosphate (1), a leading drug for type 2 diabetes, are highlighted.
No takes yet. Share an insight, caveat, or question.
Aman A. Desai (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: